A randomized trial of tirilazad mesylate in patients with acute stroke (RANTTAS)

Stroke

Volumn 27, Issue 9, 1996, Pages 1453-1458

  Haley Jr , E Clarke ^a,b   Johnston, ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cerebral ischemia; lipid peroxidation; neuroprotection; stroke, acute

Indexed keywords

TIRILAZAD;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SCREENING; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STROKE; TREATMENT OUTCOME;

EID: 0043204506     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.9.1453     Document Type: Article

References (20)

1. Wolf PA, Cobb JL, D'Agostino RB. Epidemiology of stroke. In: Barnett HJ, Mohr JP, Stein BM, Yatsu FM, eds. Stroke Pathophysiology, Diagnosis, and Management. New York, NY: Churchill Livingstone Inc; 1992:3-27.
2. Wolf PA, Kannel WB, Verter J. Current status of risk factors for stroke. Neurol Clin. 1983;1:317-343.
3. Braughler JM, Hall ED. Central nervous system trauma and stroke, I: biochemical considerations for oxygen radical formation and lipid peroxidation. Free Radic Biol Med. 1989;6:289-301.
4. Hall ED, Braughler JM. Central nervous system trauma and stroke, II: physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic Biol Med. 1989; 6:303-313.
5. Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv Pharmacol. 1994;28: 221-267.
6. Silvia RC, Piercey MF, Hoffman WE, Chase RL, Tang AH, Brughler JM. U-74006F, an inhibitor of lipid peroxidalion, protects against lesion development following experimental stroke in the cat: histologic and metabolic analysis. Soc Neurosci Symp. 1987;13:1499. Abstract.
7. Young W, Wofak JC, Decrescito V. Aminosteroid lipid peroxidation inhibitor reduces ion shifts and edema in the rat middle cerebral artery occlusion model of regional ischemia. Stroke. 1988;19:1013-1019.
8. Lythgoe W, Little RA, O'Shaughnessy CT, Steward MC. Effect of U74006F on oedema and infarct volumes following permanent occlusion of the middle cerebral artery in the rat. Br J Pharmacol. 1990;100:454P. Abstract.
9. Mori E, Ember J, Copeland BR, Thomas WS, Koziol JA, del Zoppo GJ. Effect of tirilazad mesylate on middle cerebral artery occlusion/reperfusion in nonhuman primates. Cerebrovasc Dis. 1995;5:342-349.
10. Fleishaker JC, Peters GR, Cathcart KS. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger, I: single-dose administration. J Clin Pharmacol. 1993;33:175-181.
11. Fleishaker JC, Peters GR, Cathcart KS, Steenwyk RC. Evaluation of the pharmacokinetics and tolerability of tirilazad mesylate, a 21-aminosteroid free radical scavenger, II: multiple-dose administration. J Clin Pharmacol. 1993;33:182-190.
12. STIPAS Investigators. Safety study of tirilazad mesylate in patients with acute ischemic stroke (STIPAS). Stroke. 1994;25:418-423.
13. Mahoney FT, Barthel DW. Functional evaluation: Barthel Index. Md Med J. 1965;14:61-65.
14. Jennett B, Bond M. Assessment of outcome after severe brain damage: a practical scale. Lancet. 1975;1:480-484.
15. Brott T, Adams HP Jr, Olinger CP, Marier JR, Barsan WG, Biller J, Spilker J, Holleran R, Eberle R, Hertzberg V, Rorick M, Moomaw CJ, Walker M. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989;20:864-870.
16. Brott T, Marler JR, Olinger CP, Adams HP Jr, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989;20:871-875.
17. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE III. Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial, TOAST: Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
18. Choi SC, Smith PJ, Becker DP. Early decision in clinical trials when the treatment differences are small: experience of a controlled trial in head trauma. Control Clin Trials. 1985;6:280-288.
19. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35:549-556.
20. Reboussin DM, DeMets DL, Kim K, Lan KKG. Programs for computing group sequential bounds using the Lan-DeMets method. Biostatistics Technical Report No. 60. Washington, DC: George Washington University; June 22, 1992.